| # | Drug | Count |
|---|---|---|
| 0 | CARBOPLATIN | 15 |
| 1 | METHOTREXATE SODIUM | 10 |
| 2 | CISPLATIN | 9 |
| 3 | ETOPOSIDE | 9 |
| 4 | THIOTEPA | 9 |
| 5 | CYCLOPHOSPHAMIDE | 8 |
| 6 | CYCLOPHOSPHAMIDE FOR INJECTION | 8 |
| 7 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 8 |
| 8 | METHOTREXATE | 8 |
| 9 | CAPECITABINE | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SODIUM IODIDE I 123 | 1 | 0.0011 |
| 1 | SODIUM IODIDE I 131 | 1 | 0.0010 |
| 2 | THIOTEPA | 9 | 0.0009 |
| 3 | LOMUSTINE | 2 | 0.0008 |
| 4 | INSULIN ASPART INJECTION | 1 | 0.0004 |
| 5 | LEUCOVORIN CALCIUM | 3 | 0.0002 |
| 6 | ELACESTRANT | 1 | 0.0001 |
| 7 | ETOPOSIDE | 9 | 0.0001 |
| 8 | CARBOPLATIN | 15 | 0.0001 |
| 9 | CISPLATIN | 9 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 1 | Topoisomerase Inhibitor [EPC] | 9 | 0.0001 |
| 2 | Platinum-based Drug [EPC] | 17 | 0.0001 |
| 3 | Alkylating Drug [EPC] | 13 | 0.0001 |
| 4 | Programmed Death Ligand-1 Blocker [EPC] | 1 | 0.0000 |
| 5 | Aluminum Complex [EPC] | 1 | 0.0000 |
| 6 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 7 | Nucleoside Metabolic Inhibitor [EPC] | 9 | 0.0000 |
| 8 | HER2/neu Receptor Antagonist [EPC] | 2 | 0.0000 |
| 9 | Cholinergic Muscarinic Antagonist [EPC] | 1 | 0.0000 |